| Lipsett Amphitheater | 5/12/2009 2:00 PM | | Clive Svendsen, Ph.D.
University of Wisconsin Stem Cell & Regenerative Medicine Center
| |
| Lipsett Amphitheater | 6/15/2009 2:00 PM | | | |
| Lipsett Amphitheater | 9/9/2009 2:00 PM | | Dorothy Sipkins, M.D., Ph.D.
Assistant Professor of Medicine
| Dorothy Sipkins, M.D., Ph.D. |
| Baltimore | 9/21/2009 12:00 AM | | | |
| Lipsett Amphitheater | 1/11/2010 2:00 PM | | | Margaret Goodell, PhD |
| Building 50, 1st floor | 6/3/2010 2:00 PM | | | Dr. Michael Rudnicki |
| Lipsett | 6/14/2010 2:00 PM | | Alejandro Sanchez Alvarado, Ph.D., Investigator of the Howard Hughes Medical Institute, Professor of Neurobiology and Anatomy, The University of Utah
| Alejandro Sanchez Alvarado, Ph.D. |
| Lipsett | 7/20/2010 11:00 AM | | Sean Wu, MD, PhD, Investigator, Cardiovascular Research Center, Massachusetts General Hospital
| Dr. Sean Wu |
| Lipsett | 8/3/2010 2:00 PM | | | Dr. David Traver |
| Lipsett | 9/14/2010 11:00 AM | | Allan Spradling, Ph.D. Director, Department of Embryology at Carnegie Institute Washington, Washington, DC; Principle Investigator, Howard Hughes Medical Institute
| Allan Spradling, Ph.D. |
| National Institute of Standard and Technology Main Campus,100 Bureau Drive,Gaithersburg, MD | 9/22/2010 8:00 AM | | | |
| Lipsett | 10/19/2010 2:00 PM | | | Linheng Li, Ph.D. |
| Lipsett | 11/2/2010 2:00 PM | | Brigid L.M. Hogan, Ph.D. FRS
| Brigid L.M. Hogan, Ph.D. |
| Lipsett Auditorium | 12/14/2010 11:00 AM | | | Luigi Warren, PhD |
| Lipsett Auditorium (Bldg 10) | 2/11/2011 10:00 AM | | "Alternative Sources of Human Hematopoietic Progenitors"
Mick Bhatia, PhD, Director and Senior Scientist, McMaster Stem Cell and Cancer Research Institute (SCC-RI)
http://sccri.mcmaster.ca/bhatia_mick.html
Relevant Paper:
Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 2010. Volume: 468, Pages: 521-526. | Mick Bhatia, PhD, Director and Senior Scientist, McMaster Stem Cell and Cancer Research Institute (SCC-RI) |
| Lipsett Auditorium (Bldg 10) | 3/29/2011 2:00 PM | | | Hynek Wichterle, Motor Neuron Center, Columbia Univeristy |
| Building 50 | 4/19/2011 2:00 PM | | Title: "Smith-Lemli-Opitz Syndrome: what we know and the potential for iPS technology"
Heiner Westphal Group (NICHD), Forbes Porter
http://westphal.nichd.nih.gov/
| |
| Lipsett Auditorium (Bldg 10) | 5/3/2011 10:00 AM | | Karen Hirschi, PhD
Departments of Pediatrics and Molecular & Cellular Biology
Center for Cell and Gene Therapy
Baylor College of Medicine
http://www.bcm.edu/star/?PMID=2766 | Karen Hirschi, PhD |
| Building 50 | 5/17/2011 2:00 PM | | | |
| Lipsett Auditorium (Bldg 10) | 6/7/2011 2:00 PM | | Carla Kim, PhD Children's Hospital Boston, Stem Cell Program Department of Genetics, Harvard Medical School Harvard Stem Cell Institute http://kim.tchlab.org/ | Carla Kim, PhD |
| Building 40 | 6/21/2011 2:00 PM | | | Kapil Bharti |
| Natcher - Building 45 (Auditorium) | 7/14/2011 8:00 AM | | | |
| Lipsett Auditorium (Bldg 10) | 9/6/2011 2:00 PM | | Timothy Kamp, PhD
Professor of Medicine,
Director, Stem Cell and Regenerative Medicine Center,
University of Wisconsin - Madison
http://stemcells.wisc.edu/faculty/kamp.html
Human embryonic stem cells (ESCs) and human induce pluripotent stem cells (iPSCs) can provide theoretically unlimited supplies of human cardiac myocytes(CMs) for research and potentially clinical applications. Furthermore, generation of iPSCs from genetically diverse samples will enable creation of libraries of iPSCs that will better reflect the genetic diversity of the population as well as generate disease-specific models. However, the promise of these unique cells is only starting to be realized as technical roadblocks are overcome and proof-of-principle studies are undertaken. For example, the differentiation of human pluripotent stem cells to cardiomyocytes has been highly inefficient, but here we will described a novel approach using extracellular matrix in combination with growth factors to produce in high yield and purity CMs. The presentation will also describe the use of human iPSCs to model Pompe Disease and Long QT syndrome. The final section will describe a unique cardiac progenitor cell population that we have isolated using the SRF-cardiac specific enhancer which may prove useful in cardiac repair.
| Timothy Kamp, MD, PhD |
| Building 40 - 1201/1203 | 9/20/2011 2:00 PM | | Progress and recent updates from the collaborative work of Kapil Bharti (NINDS) and Sheldon Miller's Lab (NEI).
| Kapil Bharti, PhD, NINDS (Collaboration with Sheldon Miller, NEI) |
| Natcher | 10/4/2011 12:00 AM | | | |
| Building 40 - 1201/1203 | 10/18/2011 2:00 PM | | Intramural lecture series
| William Freed, PhD |
| Lipsett Amphitheater (Bldg 10) | 11/1/2011 2:00 PM | | Elias Zambidis, MD, PhD
Departments of Pediatrics and Oncology
Johns Hopkins University
http://www.hopkinsmedicine.org/institute_cell_engineering/experts/elias_zambidis.html
He will discuss his lab's recent work in the area of reprogramming the hematopoietic lineage to pluripotency. The Zambidis lab studies the formation of pluripotent stem cells and hematopoietic, endothelial and cardiac differentiation with a focus on the potential therapeutic use of pluripotent stem cell-derived cells. Projects include studying the developmental biology of hematopoiesis as well as improving the differentiation of human embryonic stem cells and human induced pluripotent stem cells to hematopoietic lineages including erythrocytes and lymphocytes; improving the differentiation of human pluripotent stem cells to endothelial cells capable of forming the vasculature system; and improving the differentiation of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) to the cardiac lineage. The research team also studies the developmental biology of gastrulation and cardiogenesis in model organisms and explores potential applications of pluripotent stem cell-derived cardiac in tissue engineering, regenerative medicine, cardiotoxicity screening and novel drug discovery. | Elias Zambidis, MD, PhD |
| Building 50 - Lobby Conference Room | 11/15/2011 2:00 PM | | Intramural Lecture Series:
| Manfred Boehm, MD |
| Lipsett Auditorium (Bldg 10) | 12/6/2011 2:00 PM | | | Jonathan Epstein, MD |
| Building 40 - 1201/1203 | 12/20/2011 2:00 PM | | | Christopher Grunseich, MD [NINDS] |
| Lipsett Amphitheater | 2/7/2012 2:00 PM | | Jeffrey Karp, PhD, Co-Director of Regenerative Therapeutics, Harvard Stem Cell Institute
Control of cell fate and its extracellular environment is critical for tissue regeneration and cell therapy. This talk will explore methods to enhance the engraftment of systemically infused stem cells through engineering the surface of cells to induce a robust rolling response. This approach is based on leukocytes ability to target tissues via specific interactions with the vascular endothelium. In addition, a novel strategy to engineer cells with an intracellular depot of phenotype altering agents will be described that can be used for programming cell fate via both intracrine-, paracrine-, and endocrine-like mechanisms. The talk will also examine the potential of cell surface sensors that can be used to detect signals within the cellular nano-environment with unprecedented spatial and temporal resolution and that should be useful for elucidating niche biology in vivo.
| Jeffrey Karp, PhD, Co-Director of Regenerative Therapeutics, Harvard Stem Cell Institute |
| Building 50; Lobby Conference Room (1201/1203); | 2/21/2012 2:00 PM | | NIH CRM / SCIG Stem Cell Seminar; Joseph Frank, MD MS, Chief, Frank Laboratory, CC / NIBIB; Building 50; Lobby Conference Room (1201/1203); | Joseph Frank, MD MS, Chief, Frank Laboratory, CC / NIBIB |
| Building 10/ Lipsett Amphitheater | 3/6/2012 2:00 PM | | NIH CRM / SCIG Stem Cell Seminar; Joanne Kurtzberg, MD, Chief Scientific Officer, Robertson Clinical and Translational Cell Therapy Program; Building 10; Lipsett Amphitheater.
| Joanne Kurtzberg, MD, Chief Scientific Officer, Robertson Clinical and Translational Cell Therapy Program |
| Building 10; Lipsett Amphitheater | 3/13/2012 2:00 PM | | NIH CRM / SCIG Stem Cell Seminar; Norio Nakasuji, D.Sc., Director and Professor, Institute for Integrated Cell Material Sciences; Building 10; Lipsett Amphitheater; Contact Info: (301)496-6798; scott.lipnick@nih.gov
| Norio Nakasuji, D.Sc., Director and Professor, Institute for Integrated Cell Material Sciences |
| Building 50; Lobby Conference Room (1201/1203) | 4/17/2012 2:00 PM | | NIH CRM / SCIG Stem Cell Seminar; Harry Malech, MD, Chief, Laboratory of Host Diseases / Genetic Immunotherapy Section; Building 50; Lobby Conference Room (1201/1203); Contact Info: (301)496-6798; scott.lipnick@nih.gov
| Harry Malech, MD, Chief |
| Lister Hill Auditorium | 5/10/2012 9:00 AM | | NIH CRM / SCIG Stem Cell Research Symposium - 2012; Mahendra Rao, MD PhD, Director, NIH Center for Regenerative Medicine; Manfred Boehm, MD, Head, Laboratory of Cardiac Regenerative Medicine; | Mahendra Rao, MD PhD & Manfred Boehm, MD |
| Building 31 | 5/14/2012 9:00 AM | | FAES / NIH CRM: Stem Cell Industry Symposium; Mahendra Rao, MD PhD, Director, NIH Center for Regenerative Medicine; Building 60; Contact Info: 301-496-8290 or (301)496-6798; nardonem@mail.nih.gov | Stem Cell Companies & Mahendra Rao, MD, PhD |
| Building 10; Lipsett Amphitheater | 6/5/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural): Donald Ingber, PhD, Director, Wyss Institute for Biologically Inspired Engineering, Harvard University
| Donald Ingber, PhD |
| Building 10; Lipsett Amphitheater | 9/4/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Dr. Lorenz Studer
Director, Sloan Kettering Institute for Stem Cell Biology, Department of Developmental Biology
| Lorenz Studer, MD |
| Building 50, Room 1227 | 9/18/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (NIH Intramural):
Marc Ferrer, Ph.D.
Group Leader, Biology, Genome Technology Branch, NHGRI
| Marc Ferrer, Ph.D. |
| Building 10; Masur Auditorium | 10/2/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Mark Krasnow, MD, PhD
Professor and Chairman, Department of Biochemistry
Investigator, Howard Hughes Medical Institute
| Mark Krasnow, MD, PhD |
| Building 50, Room 1227 | 10/16/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (NIH Intramural):
Senior Investigator
Division of Cellular and Gene Therapies
Center for Biologics Evaluation and Research
Food and Drug Administration
| Deborah Hursh, PhD |
| Building 10; Lipsett Amphitheater | 11/6/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
| Tannishtha Reya, PhD |
| Building 50, Room 1227 | 11/20/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (NIH Intramural):
Genetics of Development and Disease Branch
Mammalian Genetics Section
NIDDK, National Institutes of Health
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
| Chuxia Deng, PhD & Yoon-Young Jang, MD, PhD |
| Building 10; Lipsett Amphitheater | 12/4/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Joseph Leidy Professor, Department of Cell and Developmental Biology
Associate Director, Institute for Regenerative Medicine
Co-Director, Epigenetics Program
University of Pennsylvania School of Medicine
| Ken S. Zaret, Ph.D. |
 | Building 50, Room 1227 | 12/18/2012 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (NIH Intramural):
Kyle Hooper, PhD, Promega Corp. - "NanoLuc™ Luciferase: A Smaller, Brighter, More Versatile Luciferase"
Sam Hasson, PhD - "Application of NanoLuc™ Luciferase in Drug Screening Assays–
Assay development for neurodegenerative disease targets: Modulating parkin expression in mitochondrial quality control"
Post Doctoral Fellow
Biochemistry Section
NINDS
| Kyle Hooper, PhD & Sam Hasson, PhD |
| Building 10; Lipsett Amphitheater | 1/8/2013 2:00 PM | | | Hesham Sadek, MD, PhD |
| Building 50, Room 1227 | 1/15/2013 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (NIH Intramural):
Raymond Tice, Ph.D.
Chief, Biomolecular Screening Branch
NIEHS
| Raymond Tice, Ph.D. |
| Building 10; Lipsett Amphitheater | 2/5/2013 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Chair and Professor, Virology
Department of Virology
City of Hope
| John A. Zaia, MD |
| Building 10, Lipsett Amphitheater | 3/5/2013 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Professor
UW Medicine Pathology
University of Washington
| Charles E. Murry, MD, PhD |
| Building 10; Lipsett Amphitheater | 4/2/2013 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Professor of Biological Structure
Director, Neurobiology and Behavior
Department Biological Structure
University of Washington
School of Medicine
| Thomas Reh, PhD |
| Building 10; Lipsett Amphitheater | 5/7/2013 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Professor of Medicine
Edythe Harris Lucas and Clara Lucas Lynn Chair in Hematology
Associate Director for Basic Research
Johns Hopkins Hematology
| Linzhao Cheng, PhD |
| Building 10; Lipsett Amphitheater | 6/4/2013 2:00 PM | | NIH CRM/SCIG Stem Cell Seminar Series (Extramural):
Associate Professor
Department of Medicine and Radiology
Stanford School of Medicine
| Joseph Wu, MD, PhD |